Pill Identifier App

Label Changes for:

Humulin R (insulin human injection, USP [rDNA origin])

February 2015

Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

February 2015

  • Apidra (insulin glulisine [rDNA origin]) injection
  • Byetta (exenatide) injection
  • Humalog (insulin lispro [rDNA origin]) injection
  • Humalog Mix 75/25 (75% insulin lispro protamine suspension /25% insulin lispro [rDNA origin]) injection
  • Humalog Mix 50/50 (50% insulin lispro protamine suspension /50% insulin lispro [rDNA origin]) injection
  • Humulin 70/30 (70% human insulin isophane suspension/30% insulin human injection, rDNA origin)
  • Humulin N NPH (human insulin isophane suspension [rNDA origin])
  • Humulin R (insulin human injection, USP [rDNA origin])
  • Lantus (insulin glargine [rDNA origin]) injection
  • Levemir (insulin detemir [rDNA origin]) injection
  • NovoLog (insulin aspart [rDNA origin]) injection
  • NovoLog Mix 50/50 (50% insulin aspart protamine suspension and 50% insulin aspart [rDNA origin]) injection
  • NovoLog Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart [rDNA origin]) injection
  • Novolin N (NPH, human insulin isophane suspension [rDNA origin]) injection
  • Symlin (pramlintide acetate) injection
  • Victoza (liraglutide [rDNA origin]) injection

WARNINGS AND PRECAUTIONS

Never share (Above Product) Pen/Flextouch/ Syringe/Needle Between Patients
  • <Product> must never be shared between patients, even if the needle is changed. Sharing poses a risk for transmission of blood-borne pathogens
  • Patients using <Product> vials must never share needles or syringes with another person
Hide
(web1)